SGAS:XETRA:XETRA-iShares MSCI USA ESG Screened UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 10.212

Change

0.00 (0.00)%

Market Cap

USD 3.80B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.08 (+0.17%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.18%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.07 (+0.27%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.24 (-0.89%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.08 (+0.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.10 (+0.77%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.04 (+0.15%)

USD 79.79B

ETFs Containing SGAS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.72% 90% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.72% 90% A- 87% B+
Trailing 12 Months  
Capital Gain 23.47% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.47% 88% B+ 86% B+
Trailing 5 Years  
Capital Gain 90.59% 92% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 90.59% 92% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 16.32% N/A N/A 87% B+
Dividend Return 16.32% N/A N/A 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.92% N/A N/A 44% F
Risk Adjusted Return 102.50% N/A N/A 97% N/A
Market Capitalization 3.80B 93% A 83% B

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike